MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0150604
Wirksam Pharma Private Limited
Wirksam Pharma Private Limited - trading in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.91 Cr
▲ 12% YoY
Net profit · FY 2024
₹4.72 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹11.05 Lakh
EBITDA margin 2.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
30
Provident fund records
Directors on board
4
As per MCA filings
About Wirksam Pharma Private Limited
Data last updated:
Wirksam Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 07 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2015PTC048194. Its GSTIN is 08AADCI9110R1Z3 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Innolife Drugs Private Limited. It is led by directors including Priyanka Rawat and Sangita.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 519A RIICO Industries Area Jothwara Extn II Sarna Dunger, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.91 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.72 Lakh (net margin 1.2%) and EBITDA of ₹11.05 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 24% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
Court records list 18 cases involving the company, including 12 filed by the company and 6 filed against it; 11 cases are pending.
Wirksam Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0150604). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232RJ2015PTC048194
Registration Number 048194
Incorporation Date 07 September 2015
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0150604
Recognitions & Rankings of Wirksam Pharma
Contact details
Wirksam Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 519A RIICO Industries Area Jothwara Extn II Sarna Dunger, Jaipur, Rajasthan, India – 302012
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Wirksam Pharma Private Limited, buy the company report.
Comprehensive company report
Wirksam Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wirksam Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wirksam Pharma Private Limited, buy the company report.
Financials of Wirksam Pharma Private Limited
FY 2025 filings availableWirksam Pharma Private Limited reported revenue of ₹3.91 Cr (up 12% YoY) for FY 2024.
Revenue · FY 2024
₹3.91 Cr ▲ 12%
Net profit · FY 2024
₹4.72 Lakh margin 1.2%
EBITDA · FY 2024
₹11.05 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▼ 8%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 25%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 12% growth in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wirksam Pharma Private Limited, buy the company report.
Board of directors of Wirksam Pharma Private Limited
Wirksam Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Rawat | Director | 07 Sep 2015 | 11 Years 1 Months | Current |
| Sangita Also directs: Sharlax Medical Devices Private Limited | Director | 26 Feb 2025 | 1 Years 7 Months | Current |
| Deepak Mittal | Director | 11 Jan 2018 | 8 Years 9 Months | Current |
| Kopal | Director | 26 Feb 2025 | 1 Years 7 Months | Current |
Auditor
Wirksam Pharma Private Limited is audited by PVA AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PVA AND ASSOCIATES | FY 2017 | 019494C |
Shareholding
The shareholding of Wirksam Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Wirksam Pharma Private Limited, buy the company report.
Legal cases
Wirksam Pharma Private Limited has 18 court cases on record: 12 filed by Wirksam Pharma, 6 filed against it. 11 cases are pending and 7 are disposed.
Total cases
18
Filed by the company
12
Filed against the company
6
Pending
11
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 10 | 0 | 8 |
| District courts | 8 | 6 | 3 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Writ petition | Filed by the company against The Chairman Rajasthan Medical Services Corporation Ltd and 2 others | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against State of Rajasthan | Pending |
| District court, Jaipur Metro II, Rajasthan | Civil miscellaneous application | Filed by the company against M/S Nem Enterprises | Pending |
| High Court, GUJARAT | Court case (SCR.A) | Filed by the company against State of Gujarat and 1 other | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Wirksam Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wirksam Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wirksam Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCI9110R1Z3 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wirksam Pharma Private Limited, buy the company report.
Recent activity
Wirksam Pharma Private Limited has 7 board changes on record since 2015: 4 appointments and 3 cessations. The latest: Priyanka Rawat ceased to be Director on 03 Jun 2025.
AGM
Wirksam Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Priyanka Rawat ceased to be Director.
Filing
Wirksam Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Deepak Mittal ceased to be Director.
Appointed
Kopal was appointed as Director.
Appointed
Sangita was appointed as Director.
Ceased
Sangita ceased to be Director.
Appointed
Deepak Mittal was appointed as Director.
Appointed
Priyanka Rawat was appointed as Director.
Incorporation
07 Sep 2015
Wirksam Pharma Private Limited was registered on 07 Sep 2015 with Roc Jaipur & aged 11 years 1 month as per MCA records.
Frequently asked questions
Wirksam Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in other wholesale, within the trading industry. It was incorporated on 07 September 2015 (11+ years old) and is registered under CIN U24232RJ2015PTC048194.
Wirksam Pharma has 4 current directors:
- Priyanka Rawat - Director
- Sangita - Director
- Deepak Mittal - Director
- Kopal - Director
The latest financial statements of Wirksam Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Wirksam Pharma is 08AADCI9110R1Z3, registered in Rajasthan.
The CIN (Corporate Identification Number) of Wirksam Pharma is U24232RJ2015PTC048194. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wirksam Pharma has 18 court cases on record: 12 filed by the company and 6 filed against it. 11 are pending. Most are in the high courts.
Wirksam Pharma was incorporated on 07 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jaipur.
Priyanka Rawat ceased to be Director on 03 Jun 2025. Deepak Mittal ceased to be Director on 03 Mar 2025. Kopal was appointed as Director on 26 Feb 2025. Wirksam Pharma has 7 board changes on record in total.
Yes, Wirksam Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0150604).
The registered office of Wirksam Pharma is at H – 519A RIICO Industries Area Jothwara Extn II Sarna Dunger, Jaipur, Rajasthan, India – 302012.